Search Publications

Search

per page

Found 461 matches. Displaying 1 - 10

[ 1 - 10 | Next ]

1. Garshick MS, Drenkova K, Kazatsker F, Boothman I, Muller M, Schlamp F, Luttrell-Williams E, Lo Sicco K, Neimann A, Scher JU, Weber B, Gelfand JM, Krueger J, Buyon J, Berger JS   Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled Psoriasis   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2025 NOV; 45(11):2086-2096 Full Text | PMID/PMCID

2. Krueger JG, Morita A, Uchida-Yamada M, Tateishi C, Ogawa E, Masuda K, Yamaguchi Y, Hur HB, Garcet S, Shishido-Takahashi N, Kanai Y   Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study   JOURNAL OF DERMATOLOGICAL SCIENCE 2025 NOV; 120(2):52-60 Full Text | PMID/PMCID

3. Han G, Armstrong A, Krueger JG, Jacobson A   IL-17C as a Driver of Inflammation in Psoriasis   ADVANCES IN THERAPY 2025 NOV; 42(11):5451-5467 Full Text | PMID/PMCID

4. Warren RB, Weiss A, Felding J, Sommer MOA, Garcet S, Krueger JG   Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis   EXPERIMENTAL DERMATOLOGY 2025 SEP 19; 34(9):? Article e70153 Full Text | PMID/PMCID

5. Krueger JG, Sarkar MK, Lebwohl MG, Morita A, Gordon K, Bogle R, Cole C, Coon A, Langley RG, Warren RB, Mostaghimi A, Strober B, Burden AD, Zheng M, Mangold AR, Anadkat MJ, Barker JN, Merola JF, Tsoi LC, Tang M, Becker K, Delic D, Thoma C, Gudjonsson JE   Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares   JOURNAL OF CLINICAL INVESTIGATION 2025 SEP 2; 135(17):? Article e188530 Full Text | PMID/PMCID

6. Imanishi I, Gill R, Wilder A, Restrepo P, Nair A, Cho IC, Krueger JG, Guttman-Yassky E, Kim BS, Ji AL   A basophil-fibroblast pro-inflammatory axis fuels type 2 skin inflammation   CELL REPORTS 2025 AUG 26; 44(8):? Article 116114 Full Text | PMID/PMCID

7. Kim J, Lee J, Lee J, Kim K, Li X, Zhou W, Cao J, Krueger JG   Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2025 JUN; 155(6):? Full Text | PMID/PMCID

8. Sachen KL, Hammaker D, Sarabia I, Stoveken B, Hartman J, Leppard KL, Manieri NA, Bao PC, Greving C, Lacy ER, Duprie M, Wertheimer J, Deming JD, Brown J, Hart A, Li H, Freeman TC, Keyes B, Kohler K, White I, Karpowich N, Steele R, Elloso MM, Fakharzadeh S, Goyal K   Guselkumab binding to CD64<SUP>+</SUP> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling   FRONTIERS IN IMMUNOLOGY 2025 MAR 12; 16(?):? Article 1532852 Full Text | PMID/PMCID

9. Farag A, Visvanathan S, Bachelez H, Morita A, Lebwohl MG, Barker JN, Choon SE, Burden AD, Tsai TF, Leparc G, Delic D, Lang B, Thoma C, Krueger JG   Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2025 MAR; 145(3):? Full Text | PMID/PMCID

10. Shishido-Takahashi N, Garcet S, Cueto I, Miura S, Li X, Rambhia D, Kunjravia N, Hur HB, Lee YI, Ham S, Anis N, Kim J, Krueger JG   Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2025 MAR; 145(3):? Full Text | PMID/PMCID

[ 1 - 10 | Next ]